Study: CBD Effective as Adjunctive Therapy for Psychosis | Paul Armentano
The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry. British researchers assessed the adjunctive use of CBD compared to placebo over a six-week period in a randomized trial of 88 schizophrenic patients. Participants ingested 1000mg of […]
Study: CBD Effective as Adjunctive Therapy for Psychosis | The Daily Chronic